Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Goadsby
096 Assessment of the Efficacy of Erenumab During the Open-Label Treatment (13–24 Weeks) of Subjects With Episodic Migraine Who Failed 2–4 Prior Preventive Treatments: Results of the LIBERTY Study
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Changes in Neurocognitive Architecture in Patients With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Pnd141 - Characteristics and Management of Migraine Patients Who Have Failed Prior Preventive Treatment in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
An Open-Label Pilot Study on the Efficacy and Tolerability of Levetiracetam in the Prophylaxis of Migraine
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Pnd67 - Are New Preventive Migraine Drugs Cost-Effective for Patients With Chronic and Episodic Migraine for Whom Other Preventive Medications Had Failed?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy of Pregabalin Versus Nortriptyline in the Treatment of Chronic Low Backache With Radiculopathy: An Open Label Observational Study
International Journal of Basic & Clinical Pharmacology
The Liberty of Open Access
PLAID: People Living with And Inspired by Diabetes
Ineffective Acute Treatment of Episodic Migraine Is Associated With New-Onset Chronic Migraine
Neurology
Neurology
Fremanezumab for Preventive Treatment of Migraine
Neurology
Neurology
Efficacy and Tolerability of Escitalopram in Treatment of Major Depressive Disorder With Anxiety Symptoms: A 24-Week, Open-Label, Prospective Study in Chinese Population
Neuropsychiatric Disease and Treatment
